HQ-461

N/A

Report date: 2023/12/15 16:33:29
NME

Base Information

Drug NameHQ-461
Drug Alias NameHQ-461HQ461
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionCyclin-dependent kinase 12 modulatorsCyclin-K degraders
TargetsCyclin-dependent kinase 12Cyclin-K
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNational Institute Of Biological Sciences, Beijing
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Biological Sciences, Beijing
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A